Articles:

D Arion, RS Fletcher, G Borkow, MJ Camarasa, J Balzarini, GI Dmitrienko, and MA Parniak

Differences in the inhibition of human immunodeficiency virus type 1 reverse transcriptase DNA polymerase activity by analogs of nevirapine and [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1", 2"- oxathiole-2",2"-dioxide] (TSAO)
Mol Pharmacol 1996 50: 1057-1064. [Abstract] [PDF]  

N Tindberg, HA Baldwin, AJ Cross, and M Ingelman-Sundberg

Induction of cytochrome P450 2E1 expression in rat and gerbil astrocytes by inflammatory factors and ischemic injury
Mol Pharmacol 1996 50: 1065-1072. [Abstract] [PDF]  

M Morissette, M Goulet, F Calon, P Falardeau, PJ Blanchet, PJ Bedard, and T Di Paolo

Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine
Mol Pharmacol 1996 50: 1073-1079. [Abstract] [PDF]  

P Perego, G Jimenez, and SB Howell

Isolation and characterization of a cisplatin-resistant strain of Schizosaccharomyces pombe
Mol Pharmacol 1996 50: 1080-1086. [Abstract] [PDF]  

JM Gimble, CE Robinson, X Wu, KA Kelly, BR Rodriguez, SA Kliewer, JM Lehmann, and DC Morris

Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells
Mol Pharmacol 1996 50: 1087-1094. [Abstract] [PDF]  

JL Nitiss and JC Wang

Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA
Mol Pharmacol 1996 50: 1095-1102. [Abstract] [PDF]  

PA Iredale, R Terwilliger, KL Widnell, EJ Nestler, and RS Duman

Differential regulation of corticotropin-releasing factor1 receptor expression by stress and agonist treatments in brain and cultured cells
Mol Pharmacol 1996 50: 1103-1110. [Abstract] [PDF]  

DC Zeldin, J Foley, J Ma, JE Boyle, JM Pascual, CR Moomaw, KB Tomer, C Steenbergen, and S Wu

CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance
Mol Pharmacol 1996 50: 1111-1117. [Abstract] [PDF]  

MM Zhao, J Hwa, and DM Perez

Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding
Mol Pharmacol 1996 50: 1118-1126. [Abstract] [PDF]  

KS Selander, J Monkkonen, EK Karhukorpi, P Harkonen, R Hannuniemi, and HK Vaananen

Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages
Mol Pharmacol 1996 50: 1127-1138. [Abstract] [PDF]  

H Kan, Y Ruan, and KU Malik

Involvement of mitogen-activated protein kinase and translocation of cytosolic phospholipase A2 to the nuclear envelope in acetylcholine- induced prostacyclin synthesis in rabbit coronary endothelial cells
Mol Pharmacol 1996 50: 1139-1147. [Abstract] [PDF]  

NA Pampori and BH Shapiro

Feminization of hepatic cytochrome P450s by nominal levels of growth hormone in the feminine plasma profile
Mol Pharmacol 1996 50: 1148-1156. [Abstract] [PDF]  

JC Corton, C Bocos, ES Moreno, A Merritt, DS Marsman, PJ Sausen, RC Cattley, and JA Gustafsson

Rat 17 beta-hydroxysteroid dehydrogenase type IV is a novel peroxisome proliferator-inducible gene
Mol Pharmacol 1996 50: 1157-1166. [Abstract] [PDF]  

RS Rogowski, JH Collins, TJ O'Neill, TA Gustafson, TR Werkman, MA Rogawski, TC Tenenholz, DJ Weber, and MP Blaustein

Three new toxins from the scorpion Pandinus imperator selectively block certain voltage-gated K+ channels
Mol Pharmacol 1996 50: 1167-1177. [Abstract] [PDF]  

JW Lawrence, DC Claire, V Weissig, and TC Rowe

Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin- treated mammalian cells
Mol Pharmacol 1996 50: 1178-1188. [Abstract] [PDF]  

KE McCarson and JE Krause

The neurokinin-1 receptor antagonist LY306,740 blocks nociception- induced increases in dorsal horn neurokinin-1 receptor gene expression
Mol Pharmacol 1996 50: 1189-1199. [Abstract] [PDF]  

V Schmieden, S Jezequel, and H Betz

Novel antagonists of the inhibitory glycine receptor derived from quinolinic acid compounds
Mol Pharmacol 1996 50: 1200-1206. [Abstract] [PDF]  

J Balzarini, H Egberink, K Hartmann, D Cahard, T Vahlenkamp, H Thormar, E De Clercq, and C McGuigan

Antiretrovirus specificity and intracellular metabolism of 2',3' - didehydro-2',3'-dideoxythymidine (stavudine) and its 5'-monophosphate triester prodrug So324
Mol Pharmacol 1996 50: 1207-1213. [Abstract] [PDF]  

Y Pak, A Kouvelas, MA Scheideler, J Rasmussen, BF O'Dowd, and SR George

Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein
Mol Pharmacol 1996 50: 1214-1222. [Abstract] [PDF]  

CT Murphy, AJ Bullock, CJ Lindley, SJ Mills, AM Riley, BV Potter, and J Westwick

Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 - trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors
Mol Pharmacol 1996 50: 1223-1230. [Abstract] [PDF]  

S Hatse, E De Clercq, and J Balzarini

Evidence for distinction of the differentiation-inducing activities and cytostatic properties of 9-(2-phosphonylmethoxyethyl)adenine and a variety of differentiation-inducing agents in human erythroleukemia K562 cells
Mol Pharmacol 1996 50: 1231-1242. [Abstract] [PDF]  

S Engelender and L De Meis

Pharmacological differentiation between intracellular calcium pump isoforms
Mol Pharmacol 1996 50: 1243-1252. [Abstract] [PDF]  

F Knoflach, D Benke, Y Wang, L Scheurer, H Luddens, BJ Hamilton, DB Carter, H Mohler, and JA Benson

Pharmacological modulation of the diazepam-insensitive recombinant gamma-aminobutyric acidA receptors alpha 4 beta 2 gamma 2 and alpha 6 beta 2 gamma 2
Mol Pharmacol 1996 50: 1253-1261. [Abstract] [PDF]  

T Asai, S Pelzer, and TF McDonald

Cyclic AMP-independent inhibition of cardiac calcium current by forskolin
Mol Pharmacol 1996 50: 1262-1272. [Abstract] [PDF]  

E Grazzini, T Durroux, MD Payet, L Bilodeau, N Gallo-Payet, and G Guillon

Membrane-delimited G protein-mediated coupling between V1a vasopressin receptor and dihydropyridine binding sites in rat glomerulosa cells
Mol Pharmacol 1996 50: 1273-1283. [Abstract] [PDF]  

AC Hargreaves, MJ Gunthorpe, CW Taylor, and SC Lummis

Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L- type Ca2+ channels
Mol Pharmacol 1996 50: 1284-1294. [Abstract] [PDF]  

SR Hoare and PG Strange

Regulation of D2 dopamine receptors by amiloride and amiloride analogs
Mol Pharmacol 1996 50: 1295-1308. [Abstract] [PDF]  

JM Masserano, L Gong, H Kulaga, I Baker, and RJ Wyatt

Dopamine induces apoptotic cell death of a catecholaminergic cell line derived from the central nervous system
Mol Pharmacol 1996 50: 1309-1315. [Abstract] [PDF]  

GE Torres, CL Arfken, and R Andrade

5-Hydroxytryptamine4 receptors reduce afterhyperpolarization in hippocampus by inhibiting calcium-induced calcium release
Mol Pharmacol 1996 50: 1316-1322. [Abstract] [PDF]  

JL Boyer, T Romero-Avila, JB Schachter, and TK Harden

Identification of competitive antagonists of the P2Y1 receptor
Mol Pharmacol 1996 50: 1323-1329. [Abstract] [PDF]  

H Suh-Kim, X Wei, and L Birnbaumer

Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker
Mol Pharmacol 1996 50: 1330-1337. [Abstract] [PDF]  

W Cho, LP Taylor, and H Akil

Mutagenesis of residues adjacent to transmembrane prolines alters D1 dopamine receptor binding and signal transduction
Mol Pharmacol 1996 50: 1338-1345. [Abstract] [PDF]  

RI Feldman, MF Bartholdi, and JM Wu

Bombesin-like peptide receptor subtypes promote mitogenesis, which requires persistent receptor signaling
Mol Pharmacol 1996 50: 1346-1354. [Abstract] [PDF]  

JM Wu, DE Nitecki, S Biancalana, and RI Feldman

Discovery of high affinity bombesin receptor subtype 3 agonists
Mol Pharmacol 1996 50: 1355-1363. [Abstract] [PDF]  

ER Whittemore, W Yang, JA Drewe, and RM Woodward

Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes
Mol Pharmacol 1996 50: 1364-1375. [Abstract] [PDF]  

TL Theroux, TA Esbenshade, RD Peavy, and KP Minneman

Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors
Mol Pharmacol 1996 50: 1376-1387. [Abstract] [PDF]  

BD Johnson, GH Hockerman, T Scheuer, and WA Catterall

Distinct effects of mutations in transmembrane segment IVS6 on block of L-type calcium channels by structurally similar phenylalkylamines
Mol Pharmacol 1996 50: 1388-1400. [Abstract] [PDF]  

PC Kearney, MW Nowak, W Zhong, SK Silverman, HA Lester, and DA Dougherty

Dose-response relations for unnatural amino acids at the agonist binding site of the nicotinic acetylcholine receptor: tests with novel side chains and with several agonists
Mol Pharmacol 1996 50: 1401-1412. [Abstract] [PDF]  

M Minami, T Nakagawa, T Seki, T Onogi, Y Aoki, Y Katao, S Katsumata, and M Satoh

A single residue, Lys108, of the delta-opioid receptor prevents the mu- opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor
Mol Pharmacol 1996 50: 1413-1422. [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.